Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Altimmune, Inc. (ALT) had Cash Flow from Investing Activities of $-132.47M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.03M |
|
$-27.36M |
|
-- |
|
$0.03M |
|
$28.92M |
|
$-28.89M |
|
$1.53M |
|
$-27.36M |
|
$-27.36M |
|
$-27.36M |
|
$-27.36M |
|
$-27.36M |
|
$-27.36M |
|
$-28.89M |
|
$-29.59M |
|
88.10M |
|
88.10M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$278.19M |
|
$0.31M |
|
$1.74M |
|
$279.93M |
|
$15.00M |
|
$34.29M |
|
$40.04M |
|
$55.04M |
|
$224.89M |
|
$224.89M |
|
$224.89M |
|
110.88M |
|
| Cash Flow Statement Financials | |
$-67.53M |
|
|
Cash Flow from Investing Activities |
$-132.47M |
$206.84M |
|
$36.97M |
|
$43.80M |
|
$6.83M |
|
$16.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.55 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
100.00% |
|
-111126.90% |
|
-111126.90% |
|
-- |
|
-105223.10% |
|
-105223.10% |
|
$-67.55M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
6012.69 |
|
-12.16% |
|
-12.16% |
|
-9.77% |
|
-10.56% |
|
$2.03 |
|
$-0.77 |
|
$-0.77 |
|